C-Biotech

Skip to content

CHECKED

Companies Insolvencies Sectors Watchlist Alerts API

Sign in

C-Biotech

Temse ·KBO/BCE: BE 0794.909.852

Loading dossier…

Checked · Insight, alerts and connections for every Belgian company, from official sources.

NL FR EN

Product

Search companies Sectors Radar Live Compare Prospects Supplier check Feasibility Decision tools Company map

Data & registers

Insolvencies Curators Directors Director bans Protection orders Notaries News

Account

Watchlist Portfolio Alerts Pricing

Checked

About Methodology Knowledge base Sources FAQ Help API Developers Badge Business information compared Free company information

Legal

Privacy Terms Contact

Checked AI

Open a company dossier to ask Checked AI about it.

Your question travels, with the dossier's public data, to our AI model at Anthropic in the US. Nothing that identifies you goes along, and we keep neither question nor answer. Answers can be wrong, so this is not legal advice. How it works

Metric	This company	Sector median	Position in the sector
Solvency	7.3%	30.0%	better than 24% of 37 sector peers
Net result	€-629k	€7k	better than 5% of 36 sector peers
Equity	€195k	€28k	better than 84% of 37 sector peers
Gross operating margin	€-436k	€31k	better than 5% of 37 sector peers
Total assets	€2.67M	€108k	better than 90% of 37 sector peers

Fiscal year	2024
Revenue	€97k
EBITDA	€-544k
Net profit	€-629k
Cash flow	€-591k
Staff costs	€107k
Income taxes	-
Dividends	-
Total assets	€2.67M
Equity	€195k
Debt	€2.48M
of which ≤ 1y	€2.35M
of which > 1y	-
Working capital	€-821k
Employees (FTE)	1.8

	2024
Current ratio	0.65
Quick ratio	0.45
Working capital ratio	-30.7%
Solvency	7.3%
Debt / equity	12.72
Long-term debt ratio	-
Interest coverage	-11.58
Gross margin	-528.7%
Net margin	-647.2%
ROA	-23.5%
ROE	-322.8%
EBITDA margin	-560.2%
Days sales outstanding	294d
Days payable outstanding	262d
Inventory turnover	1.27
Days inventory (DSI)	288d

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€2.67M
Fixed assets	21/28	€991k
Formation expenses	20	€152k
Intangible fixed assets	21	€375k
Tangible fixed assets	22/27	€151k
Financial fixed assets	28	€466k
Current assets	29/58	€1.53M
Stocks & contracts in progress	3	€482k
Amounts receivable within one year	40/41	€431k
Cash & bank	54/58	€616k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€2.67M
Equity	10/15	€195k
Contributions / capital	10/11	€1.25M
Accumulated profits (losses)	14	€-1.06M
Amounts payable	17/49	€2.48M
Amounts payable within one year	42/48	€2.35M
Trade debts payable within one year	44	€439k
Income statement
Turnover	70	€97k
Gross operating margin	9900	€-436k
Operating result	9901	€-582k
Financial income	75	€3
Financial charges	65	€47k
Result before taxes	9903	€-629k
Net result for the period	9904	€-629k
Result to be appropriated	9905	€-629k

Summary

Conclusion

Bankruptcy probability (12 mo)

Signals

Trust signals

Administrative Flags

Financials

Annual accounts & ratios

Health barometer

Structure & network

Locations & real estate

Registered office

Establishment units

Real-estate footprint

Publications

Lifecycle & Insolvency Signals

Belgisch Staatsblad · acts

Analysis

Snowflake analysis

Ask AI about this company

AI due-diligence brief

Credit advice

Similar

Similar companies

Company registry

Company registry (CBE)